
NYSE:CE
This summary was created by AI, based on 1 opinions in the last 12 months.
Celanese Corporation, symbol CE-N, is a company that plays a crucial role in the production of various chemicals essential to everyday products, including food items, fabrics, and pharmaceuticals. Although the pricing background has historically been weak, indicating the cyclical nature of the industry, analysts are beginning to see early signs of a bottoming trend, which could present a significant opportunity for investors. The stock has a modest yield of 0.23%, and analysts project a price target of $71.17, suggesting potential for growth. Timing remains critical for those looking to capitalize on the possible rebound in pricing and overall performance.
Big correction that he calls a 4-year-cycle reset. October 13 was the start of a new 4-year cycle. Should have upside, by time, into late 2025 to early 2026. One of his favourite plays for this year. Higher lows, higher highs. If it continues to take out recent highs, sees no reason it won't test important resistance around $150, where it stalled out before.
Celanese Corporation is a American stock, trading under the symbol CE (previously CE-N on Stockchase) on the New York Stock Exchange (CE). It is usually referred to as NYSE:CE or CE
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on CE (previously CE-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY on WEAKNESS. Read the latest stock experts' ratings for Celanese Corporation .
Celanese Corporation was recommended as a Top Pick by Gordon Reid on 2026-09-09. Read the latest stock experts ratings for Celanese Corporation .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Celanese Corporation .
Celanese Corporation is followed by 8 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-09, Celanese Corporation (CE) stock closed at a price of $44.29.
In his US small-cap portfolio. Thinks the pricing environment is bottoming. Chinese production and subsidies have been issues, pricing in the chemical space in general has been subdued. Pricing is starting to firm up. Cyclical, so you have to time your entry. Modest multiple. Upside to earnings could be sharp.